Leading Neuro-Oncologist – Brain tumors treatment
Position: Senior specialist
Hospital: Hadassah Medical Center
Professor Tali Siegel founded the Israeli Neuro-Oncology Forum. Established several research laboratories in the field of neurooncology and treatment of brain cancer and central nervous system cancer. Israel’s representative in the Medical Society of London, The New York Academy of Sciences.
Professor Tali Siegel is in the Forbes list of the best Israeli doctors
Consultation Online, Second Opinion
Professional Consultation
Meningioma, Pituitary tumors, Glioma, Glioblastoma, Medulloblastoma, Craniopharyngioma, Pineal region tumors, Ependymoma, Primary central nervous system lymphoma. All kinds of metastatic brain and nervous system tumors.
Send Your Medical Files Book an Appointment
Treatments Provided:
Standard protocols and advanced treatment:
- Liquid biopsy (blood sampling) without surgery
- Chemotherapy
- Targeted therapy
- Immunotherapy of Brain and Nervous System Tumors
- Personalized treatment
- Experimental treatments for brain tumor
Education:
Graduated from the School of Medicine, Tel Aviv University, Israel
Academic experience and teaching:
Prof. Siegal trained the majority of experts currently working in Israel in the field of neuro-oncology.
- Specialization in neurology at Sheba Medical Center and Hadassah Medical Center in Jerusalem.
- Specialization in neuro-oncology at the cancer center of Memorial Sloan Kettering Hospital in New York.
- Trainer in Neurology, Hebrew University and Hadassah Medical School, Jerusalem, Israel.
- Full professor at the Hebrew University, Israel
Clinical experience:
- Hadassah Hospital in Israel.
- Daniel den Hoed Cancer Center, Rotterdam, The Netherland.
- Center for Neuro-Oncology at the Oncology Institute in Beilinson, the Davidoff Oncology Institute at the Rabin-Beilinson Medical Center.
Research and scientific activities:
Prof. Tali Siegal established the first Neuro-oncology Center with the research laboratory and a laboratory for molecular diagnosis of brain tumors at Hadassah Hospital in Israel.
In 2014, she established the Neuro-Oncology Center at the Davidoff Oncology Institute at the Rabin-Bilinson Medical Center in Petah Tikva, where she continues her clinical work, research and teaching.
Prof. Siegal founded the Forum for Neuro-Oncology, which is a multidisciplinary professional forum in the field of neuro-oncology.
Prof. Tali Siegal serves as a reviewer of professional articles both in the field of basic neurology research and in clinical studies sent for publication in scientific journals – about 160 scientific publications. She also participates in international scientific conferences in the field of brain tumors.
Part of the research work carried out by prof. Siegal:
- Height as a risk factor in meningioma: a study of 2 million Israeli adolescents.
- Central nervous system metastases in breast cancer
- Patients treatment with nervous system lymphoma using targeted therapy – ibrutinib and methotrexate based chemotherapy
- Clinical impact of molecular biomarkers in gliomas.
Membership in professional organizations:
- Israel Medical Association
- Israel Neurological Association
- Israel Oncological Association
- The Medical Society of London
- American Academy of Neurology
- The New York Academy of Sciences
- European Neurological Society
- European Association of Neuro-Oncology
- The Society for Neuro-Oncology
- European Federation for Neurological Sciences
- and Intenation Extranodal Lymphoma Study Group.
Leading Israeli neurooncologist Tali Siegal leads clinical studies in brain tumors with using personalized treatments, immunotherapy and biological treatments. Furthermore, she specializes in liquid biopsy (blood sampling) – detection of molecular markers in various types of brain tumors. This approach is less invasive than traditional methods of obtaining tumor samples, such as surgery, and can be used for more effective treatments and better outcomes.
Prof. Tali Siegal provides Second Opinion and Consultation Online in Israel regarding the initial treatment decision for brain and nervous system cancer.
